Emerald Mutual Fund Advisers Trust Ultragenyx Pharmaceutical Inc. Transaction History

Emerald Mutual Fund Advisers Trust

$1.23 Billion
Q1 2025

A detailed history of Emerald Mutual Fund Advisers Trust transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 340,975 shares of RARE stock, worth $13.3 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

340,975

Previous 324,437 5.1%

Holding current value

$13.3 Million

Previous $13.6 Million 9.55%

% of portfolio

1.0%

Previous 0.94%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$36.21 - $45.78 $598,840 - $757,109	16,538 Added 5.1%	340,975 $12.3 Million
Q4 2024 Feb 14, 2025	SELL	$42.07 - $57.72 $4.41 Million - $6.05 Million	-104,865 Reduced 24.43%	324,437 $13.6 Million
Q3 2024 Oct 29, 2024	BUY	$40.21 - $59.36 $1.56 Million - $2.3 Million	38,778 Added 9.93%	429,302 $23.8 Million
Q2 2024 Aug 06, 2024	BUY	$37.42 - $51.61 $193,985 - $267,546	5,184 Added 1.35%	390,524 $16.1 Million
Q4 2023 Feb 05, 2024	SELL	$31.73 - $49.19 $62,920 - $97,543	-1,983 Reduced 0.51%	385,340 $18.4 Million
Q3 2023 Oct 26, 2023	SELL	$34.92 - $46.66 $1.84 Million - $2.46 Million	-52,818 Reduced 12.0%	387,323 $13.8 Million
Q2 2023 Aug 10, 2023	BUY	$37.35 - $52.15 $1.93 Million - $2.69 Million	51,613 Added 13.28%	440,141 $20.3 Million
Q1 2023 May 04, 2023	BUY	$36.99 - $48.71 $5.02 Million - $6.61 Million	135,676 Added 53.66%	388,528 $15.6 Million
Q4 2022 Feb 03, 2023	BUY	$33.72 - $46.33 $493,930 - $678,641	14,648 Added 6.15%	252,852 $11.7 Million
Q3 2022 Oct 25, 2022	BUY	$39.96 - $66.14 $2.87 Million - $4.75 Million	71,866 Added 43.2%	238,204 $9.86 Million
Q2 2022 Jul 29, 2022	SELL	$45.8 - $85.4 $726,662 - $1.35 Million	-15,866 Reduced 8.71%	166,338 $9.92 Million
Q1 2022 Apr 29, 2022	SELL	$62.2 - $84.4 $3.64 Million - $4.94 Million	-58,565 Reduced 24.32%	182,204 $13.2 Million
Q4 2021 Feb 02, 2022	BUY	$73.71 - $87.86 $10.2 Million - $12.2 Million	138,892 Added 136.33%	240,769 $20.2 Million
Q3 2021 Oct 28, 2021	SELL	$77.92 - $102.4 $9.52 Million - $12.5 Million	-122,205 Reduced 54.54%	101,877 $9.19 Million
Q2 2021 Jul 29, 2021	SELL	$92.19 - $115.71 $1.38 Million - $1.73 Million	-14,941 Reduced 6.25%	224,082 $21.4 Million
Q1 2021 Apr 29, 2021	BUY	$106.9 - $167.73 $2.21 Million - $3.46 Million	20,633 Added 9.45%	239,023 $27.2 Million
Q4 2020 Jan 29, 2021	BUY	$84.4 - $177.39 $18.4 Million - $38.7 Million	218,390 New	218,390 $30.2 Million

Others Institutions Holding RARE

# of Institutions

341

Shares Held

84.7M

Call Options Held

675K

Put Options Held

846K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.73B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account

Emerald Mutual Fund Advisers Trust Ultragenyx Pharmaceutical Inc. Transaction History